JPRN-jRCT2080221887未知1 期
PET Whole Body Biodistribution Using Florbetapir (18F)
适应症
试验速览
- 阶段
- 1 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 45age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Japanese cognitively normal healthy males or females at least 45 years of age.
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A Study of Florbetapir (18F) in Japanese Healthy VolunteersAlzheimer's DiseaseNCT01660815Avid Radiopharmaceuticals7
已完成
1 期
A Study of 18F-AV-45 in Healthy VolunteersAlzheimer DiseaseNCT01564706Avid Radiopharmaceuticals9
进行中（未招募）
不适用
To test the effectiveness of florbetapir (18F) as a diagnostic tool in subjects particpiating in the IRCCS-FBF protocolEUCTR2012-003079-20-ITAVID RADIOPHARMACEUTICALS, INC.
已完成
1 期
Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- TrastuzumabSolid TumorsNCT00613847Memorial Sloan Kettering Cancer Center17
已完成
不适用
Establishment of a (18)F-florbetaben PET normative database of Japanese nondemented subjects and its application to detection of early cortical amyloid depositioJPRN-UMIN000025420Keio University School of Medicine120